Isomorphic Labs Raises $2.1B for AI Drug Discovery
LONDON, May 12, 2026 Isomorphic Labs has secured a massive $2.1 billion Series B funding round to accelerate the...
Biotech Investment
Advertisement
Fathom Therapeutics Raises $47M to Advance AI Drug Design
NEW YORK, April 27, 2026 Fathom Therapeutics has announced the successful completion of an oversubscribed $47 million Series A...
Blackstone Raises $6.3B Life Sciences Fund Record
NEW YORK & CAMBRIDGE, Mass., USA, March 30, 2026 Blackstone has announced the final close of Blackstone Life Sciences...
CNS Pharmaceuticals Launches Strategy to Build Neurology and Oncology Drug Pipeline
Houston, Texas, United States — March 11, 2026 Biotechnology company CNS Pharmaceuticals has announced the launch of a new...
Dianthus Therapeutics Prices $250M Public Offering
New York, United States — March 10, 2026 Biotechnology company Dianthus Therapeutics has announced the pricing of an upsized...
Advertisements
BioXcel Therapeutics Secures $8M Registered Direct Offering
NEW HAVEN, Connecticut — March 10, 2026 Biotechnology company BioXcel Therapeutics Inc. has announced a registered direct offering expected...
Dianthus Therapeutics Launches $400M Public Offering Plan
New York, United States & Waltham, Massachusetts – March 9, 2026 Dianthus Therapeutics, Inc., a clinical-stage biotechnology company focused...
Trimmune JV Financing Fuels Next-Gen Immunotherapy Development
MIRAMAR, Fla., Feb. 16, 2026 — Clinical-stage immunotherapy innovator HCW Biologics and recombinant biologics developer WY Biotech have closed...
Portal Innovations Expands Life Sciences Incubator Network
PROVIDENCE, R.I., Feb. 11, 2026 — Portal Innovations announced the expansion of its Powered by Portal venture development platform...
4Moving Biotech Raises €12M for OA Drug Development
Lille & Paris, France — February 10, 2026: 4Moving Biotech (4MB), a clinical-stage biotechnology company and spin-off of 4P-Pharma,...
Advertisement
